Back to Deals
Value Undisclosed
MTL Projects and Mark Thompson Lifesciences
M&A Exit
Exited
Business Services
Published 3 December 2024
Summary
Normec Group, a Netherlands-based leader in testing, inspection, certification, and compliance, has acquired MTL Projects and Mark Thompson Lifesciences. The transaction integrates specialized engineering and consultancy services into Normec's healthcare division, focusing on the pharmaceutical, biotech, and medical device industries.
Summary of transaction details:
- Value: Not Disclosed
- Sector: Business Services
- Advisor: KBS Corporate
- Key Entities: Normec Group, MTL Projects, Mark Thompson Lifesciences, KBS Corporate
- Location: Bishop Auckland, United Kingdom
Note: The acquisition is intended to act as a catalyst for growth, leveraging Normec's scale to expand the service offerings of the acquired engineering and validation specialists.
Related Deals in Business Services
Exited prioritisedOriginal Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in